Idiopathic pulmonary pneumonia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Samples of the institution, of which institutional review board allowed to provide samples to an institution outside. 2) Samples taken from the patients who provided written informed consent. 3) Samples enrolled in the institution that participates in NEJ030 study. Samples collected in the Jichi Medical University is not allowed.
Exclusion criteria
Exclusion criteria: 1) Samples taken from patients who is considered inappropriate for the inclusion by the responsible physician of each institution. 2) Samples taken from patients who refused to use their samples for the genetic analysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The predictive value of the Telomere length, TERT, TERC, MUC5B, MUC4, TOLLIP, SFTPA2 polymorphisms/mutations for the development, clinical course, classification and response to drugs of idiopathic pulmonary pneumonias. | — |
Secondary
| Measure | Time frame |
|---|---|
| The association of the Telomere length, TERT, TERC, MUC5B, MUC4, TOLLIP, SFTPA2 polymorphisms/mutations for the development, clinical course, classification and response to drugs of idiopathic pulmonary pneumonias. Bank the immortalized lymphocytes for the future studies that investigate the association of the development of IIPs with the novel genetic biomarkers. | — |
Countries
Japan
Contacts
Jichi Medical University Division of Pulmonary Medicine, Department of Internal Medicine